EVALUATING THE EPIDEMIOLOGICAL IMPACT OF INTRODUCTION OF PNEUMOCOCCAL CONJUGATE VACCINE AS PART OF THE NATIONAL IMMUNIZATION SCHEDULE OF KAZAKHSTAN

被引：0
作者：
Balabayev, T. [1 ]
Kostyuk, A. [2 ]
Almadiyeva, A. [3 ]
Sultanov, M. [3 ]
Absattarova, K. [3 ]
Almatova, V [3 ]
机构：
[1] Kazakhstan Assoc HTA EBM & Pharmacoecon Res KazSP, Astana, Kazakhstan
[2] Kazakhstan Assoc HTA EBM & Pharmacoecon Res KazSP, Alma Ata, Akm, Kazakhstan
[3] Kazakh Agcy Hlth Technol Assessment, Astana, Kazakhstan
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.1738
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRS34
引用
收藏
页码：S355 / S355
页数：1
相关论文
共 50 条
  • [31] Reduction of IPD in children as a result of the German National Immunization program for pneumococcal conjugate vaccine.
    van der Linden, M.
    Siedler, A.
    Burckhardt, F.
    von Kries, R.
    Imoehl, M.
    Reinert, R. R.
    Rueckinger, S.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2009, 299 : 86 - 86
  • [32] Reassessing the 1+1 pneumococcal conjugate vaccine schedule
    Perniciaro, Stephanie
    van der Linden, Mark
    LANCET INFECTIOUS DISEASES, 2018, 18 (04) : 381 - 382
  • [33] Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule
    George A. Syrogiannopoulos
    Ioanna N. Grivea
    Maria Moriondo
    Francesco Nieddu
    Aspasia N. Michoula
    Maria Rita Calabrese
    Michael Anthracopoulos
    Chiara Azzari
    Scientific Reports, 11
  • [34] Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)
    Artiles, Fernando
    Horcajada, Iballa
    Maria Canas, Ana
    Alamo, Isabel
    Bordes, Ana
    Gonzalez, Agustin
    Santana, Milagrosa
    Lafarga, Bernardo
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (01): : 14 - 21
  • [35] IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINE (PCV-10) ON PNEUMOCOCCAL NASOPHARYNGEAL CARRIAGE IN CHILDREN IN PAKISTAN: RESULTS OF SERIAL SURVEYS PRE AND POST INTRODUCTION OF VACCINE IN ROUTINE IMMUNIZATION PROGRAM
    Nisar, Imran
    Riaz, Atif
    Kabir, Furqan
    Jehan, Fyezah
    Ali, Asad
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 97 (05) : 580 - 580
  • [36] Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine
    Hirose, Tatiane E.
    Maluf, Eliane M. C. P.
    Rodrigues, Cristina O.
    JORNAL DE PEDIATRIA, 2015, 91 (02) : 130 - 135
  • [37] Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia
    Suwantika, Auliya A.
    Zakiyah, Neily
    Kusuma, Arif S. W.
    Abdulah, Rizky
    Postma, Maarten J.
    VACCINES, 2020, 8 (02)
  • [38] Cost-effectiveness of a national immunization program with the 13-valent pneumococcal conjugate vaccine compared with the 10-valent pneumococcal conjugate vaccine in South Korea
    Kim, Hye-Young
    Park, Seong-Beom
    Kang, Eun-Sil
    Lee, Sang-Min
    Kim, Hyun-Jin
    Wasserman, Matt
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (03) : 909 - 918
  • [39] Benefits and costs of immunization of children with pneumococcal conjugate vaccine in Canada
    De Wals, P
    Petit, G
    Erickson, LJ
    Guay, M
    Tam, T
    Law, B
    Framarin, A
    VACCINE, 2003, 21 (25-26) : 3757 - 3764
  • [40] Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations
    Naucler
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (03) : 534 - 534
12345